GlassScriptPhysician profile
Gregory C Lieser
NPI 1083858518
$3,068.58
in general payments reported to CMS, 2019-2025
37 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $262 · 2021: $137 · 2022: $550 · 2023: $1,038 · 2024: $299 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566 · Travel and Lodging: $38.00 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.56 |
| Travel and Lodging | $38.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $653.77 | 2023-2024 | Da Vinci Surgical System |
| Astellas Pharma US INC | $385.42 | 2019-2024 | Myrbetriq |
| Boston Scientific Corporation | $292.36 | 2019-2025 | General - Erectile Dysfunction |
| Olympus America INC. | $161.65 | 2020-2023 | Itind System |
| Sumitomo Pharma America, INC. | $134.35 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $112.52 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $105.38 | 2019-2022 | |
| Innovation Technologies INC | $94.83 | 2022-2024 | Irrisept |
| Pfizer INC. | $94.37 | 2020-2024 | |
| Ethicon US, LLC | $90.69 | 2023-2024 | Echelon; Endopath |
| Novartis Pharmaceuticals Corporation | $81.17 | 2023-2024 | |
| Janssen Biotech, INC. | $64.77 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.80 | 2019-2020 | |
| Conmed Corporation | $63.69 | 2019 | |
| Abbvie INC. | $63.56 | 2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $58.73 | 2019-2025 | Xyosted |
| Endo Pharmaceuticals INC. | $56.22 | 2019-2023 | Aveed, Xiaflex |
| Merck Sharp & Dohme LLC | $45.71 | 2020-2024 | Lynparza |
| Acclarent, INC | $41.47 | 2023 | Trudi Nav Cable |
| Urogen Pharma, INC. | $36.37 | 2022-2023 | Jelmyto |
| Baxter Healthcare | $33.37 | 2019 | |
| Ge Healthcare | $29.77 | 2025 | |
| Biotissue Holdings INC. | $27.05 | 2022 | |
| Tempus Ai, INC | $26.05 | 2025 | Xt Cdx |
| Sun Pharmaceutical Industries INC. | $25.69 | 2022 | |
| Blue Earth Diagnostics | $24.92 | 2024 | |
| Levita Magnetics International Corp | $22.99 | 2019 | |
| Travere Therapeutics, INC. | $21.12 | 2019 | |
| Integra Lifesciences Corporation | $19.55 | 2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Endo USA, INC. | $19.49 | 2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $19.34 | 2022 | |
| Calyxo, INC. | $19.16 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $18.20 | 2025 | |
| Acerus Pharmaceuticals Corporation | $16.77 | 2022 | |
| Neotract INC. | $16.25 | 2019 | |
| Medtronic, INC. | $14.29 | 2024 | Signia |
| Myriad Genetic Laboratories, INC. | $13.74 | 2025 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lieser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.